Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC
Clinical trial NCT03706287 · UNKNOWN
Trial details
- NCT number
- NCT03706287
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-06
- Primary completion
- 2021-03-10
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.